Skip to main content

Articles

Novel CAR-T Therapy Topped the News at ASH 2013

Leukemia, Oncology

Novel Anti-CD20 Antibodies Show Promising Results in Unfit Patients with Chronic Lymphocytic Leukemia

Rituximab Infusions Costlier When Given in the Hospital

Hematologists Urged to Reduce Unnecessary Tests/Procedures, and Costs to Improve Quality of Care

Peripheral T-Cell Lymphoma Associated with High Clinical Burden, Resource Utilization, and Costs

Significant Hospital Costs Tied to 30-Day Readmissions for Allogeneic Transplants

Physicians Must Consider the Financial Burden of Allogeneic Transplants

Clinical Practice Guidelines Should Include Patient’s Preferences

Adverse Events Reporting in Oncology Studies Suboptimal

Ibrutinib Approved for Chronic Lymphocytic Leukemia

Page 159 of 244
Results 1581 - 1590 of 2436